In this review piece, we take a look at the most read cancer news stories from over the past year; highlights include drug approvals, genetic discoveries and immunotherapy advancements.
Browsing: Disease Area > Brain and neurologic
Researchers at the University of California (CA, USA) have discovered a neoantigen in a rare childhood brain tumor that binds strongly to T cells.
Researchers at Cancer Research UK have discovered a potential combination treatment for glioblastoma, by exploiting leaks in the blood-brain barrier.
Researchers at Massachusetts General Hospital (MA, USA) report the first response to chimeric antigen receptor (CAR) T-cells in a central nervous system lymphoma.
Novel research has indicated a distinct group of circulating tumor cells that are associated with breast cancer brain metastases, the findings may help detect the tumors while they are still treatable.
New research looking at childhood cancer survivors has suggested that radiation therapy could trigger genomic structural rearrangements, providing a genetic basis for meningioma later in life.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
A new assay test for five cancer-associated genes with the goal of aiding prediction of neuroblastoma in children has been reported.
The European Commission has recently approved dinutuximab beta for high risk neuroblastoma patients over the age of 12 months, making it the only approved immunotherapy in Europe for this group of patients.